BioCorRx (BICX) EBITDA Margin Growth (3y) (2014 - 2026)
BioCorRx (BICX) EBITDA Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -1,299.00 |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 1,213.00 |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 282.00 |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | -600.00 |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 54.00 |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 315.00 |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 492,237.00 |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | -15.00 |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 314.00 |
| 10 | BioCorRx | - | - | 189,355.00 | 215,178.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215,178.00 |
| Dec 31, 2025 | 123,466.00 |
| Sep 30, 2025 | 62,131.00 |
| Jun 30, 2025 | 765,666.00 |
| Mar 31, 2025 | 475,689.00 |
| Jun 30, 2024 | -2.76 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Dec 31, 2023 | 360,780.00 |
| Sep 30, 2023 | -255,499.00 |
| Jun 30, 2023 | 157,735.00 |
| Mar 31, 2023 | 150,273.00 |
| Dec 31, 2022 | 112,375.00 |
| Sep 30, 2022 | 80,780.00 |
| Jun 30, 2022 | -602,770.00 |
| Mar 31, 2022 | -274,037.00 |
| Dec 31, 2021 | -598,219.00 |
| Sep 30, 2021 | -1.67 Mn |
| Jun 30, 2021 | -532,218.00 |
| Mar 31, 2021 | -1.49 Mn |
| Dec 31, 2020 | -729,550.00 |